FEV1/FVC Ratio Calculator

The FEV1/FVC Ratio Calculator determines the ratio of forced expiratory volume in one second (FEV1) to forced vital capacity (FVC), the fundamental spirometric parameter for identifying obstructive lung disease. This ratio is the cornerstone of pulmonary function interpretation and the primary criterion for diagnosing conditions such as COPD, asthma, and other obstructive airway diseases.

FEV1 is the volume of air forcefully exhaled in the first second of a maximal expiration. FVC is the total volume exhaled during the entire forced expiration. In healthy lungs, approximately 75-80% of the FVC is exhaled in the first second. A reduced FEV1/FVC ratio indicates airflow obstruction: air cannot be expelled as rapidly due to airway narrowing, inflammation, or loss of elastic recoil.

The lower limit of normal (LLN) for FEV1/FVC decreases with age, reflecting normal age-related changes in lung elasticity. The fixed 0.70 threshold (GOLD criteria) is widely used for COPD diagnosis but may overdiagnose obstruction in elderly patients and underdiagnose in younger patients. Using age-specific LLN (5th percentile from GLI-2012 reference equations) is more physiologically accurate.

When obstruction is identified (ratio below LLN), GOLD staging classifies severity by FEV1 percent predicted: GOLD 1 (Mild) FEV1 at least 80%, GOLD 2 (Moderate) 50-79%, GOLD 3 (Severe) 30-49%, GOLD 4 (Very Severe) below 30%. GOLD staging guides COPD pharmacotherapy and predicts mortality, hospitalization rates, and quality of life deterioration.

A normal or elevated FEV1/FVC with reduced FVC suggests restrictive physiology (pulmonary fibrosis, chest wall disease, neuromuscular weakness), but confirmation requires total lung capacity (TLC) measurement by body plethysmography. Combined obstructive-restrictive patterns show reduced ratio with disproportionately reduced FVC relative to FEV1.

Post-bronchodilator spirometry is essential for COPD diagnosis and asthma evaluation. An increase in FEV1 of at least 200 mL and 12% from baseline after bronchodilator administration confirms significant reversibility, characteristic of asthma. COPD typically shows incomplete or absent reversibility, though some overlap exists.